awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27301948-A25E4F1E-9E61-4154-84E2-F6778B04A60E
Q27301948-A25E4F1E-9E61-4154-84E2-F6778B04A60E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27301948-A25E4F1E-9E61-4154-84E2-F6778B04A60E
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.
P2860
Q27301948-A25E4F1E-9E61-4154-84E2-F6778B04A60E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27301948-A25E4F1E-9E61-4154-84E2-F6778B04A60E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4874e2e442e28784833834ef6ea55bd9136f127d
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.